NEW YORK (GenomeWeb) – Bio-Reference Laboratories today said that its fiscal first quarter revenues grew 15 percent year over year but missed the average analysts' estimates on the top and bottom lines.

For the three months ended Jan. 31, Bio-Reference recorded $208.8 million in revenues, up from $181.3 in the year-ago first quarter, but below the consensus Wall Street estimate of $216 million. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.